LGND
Ligand Pharmaceuticals IncCompany with tickers: LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ
CIK
886163
CUSIP
53220K504
Shares Outstanding
20,041,061
Website
https://www.ligand.com
Investor Relations
https://investor.ligand.com/overview/default.aspx
13F Activity (30d)
87 filings
65 filers
Price
$255.54
Market Cap
$5.12B
P/E Ratio
86.92
EPS (Diluted)
$2.94
52W High
$259.03
52W Low
$110.00
Daily open, high, low and close prices with derived technical indicators (moving averages, RSI and more). Price data syncs automatically from Yahoo Finance.
Latest guidance
from the 8-K filed May 7, 2026
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
| adjusted earnings per diluted share | full-year 2026 | $8.50 – $9.50 | Non-GAAP | — |
| royalty revenue | full-year 2026 | $225M – $250M | — | — |
| Revenue from sales of Captisol | full-year 2026 | $35M – $40M | — | — |
| contract revenue | full-year 2026 | $10M – $20M | — | — |
| total revenue | full-year 2026 | $270M – $310M | — | — |
9 Up Days
Price, Moving Averages & Bollinger Bands
RSI (14)
MACD (12, 26, 9)
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LGND | +7.8% | +16.7% | +28.8% | +10.2% | +35.2% |
| SPY | +0.6% | -0.9% | +9.7% | -2.0% | +8.8% |
| vs SPY | +7.3% | +17.6% | +19.1% | +12.1% | +26.4% |
Close
$255.54
Open
$254.99
52W High
$259.03
52W Low
$110.00
Avg Vol (30d)
188K
Data Range
2020-01-02 — 2026-06-12